Suchergebnisse - "Zaccaria, Gian Maria"

PubPharm (24)

1

SurvIAE : Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression data

enthalten in: Computer methods and programs in biomedicine | 2024

von Zaccaria, G. | Altini, N. | Mezzolla, G. | +6

2

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma : the Fondazione Italiana Linfomi MCL0208 trial

enthalten in: Blood advances | 2023

von Ferrero, S. | Grimaldi, D. | Arrigoni, E. | +25

3

ARGO 2.0 : a Hybrid NLP/ML Framework for Diagnosis Standardization

enthalten in: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference | 2023

von Berloco, F. | Ciavarella, S. | Colucci, S. | +3

4

A Decision-tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment Determinants

enthalten in: HemaSphere | 2023

von Zaccaria, G. | Vegliante, M. | Mezzolla, G. | +15

5

Lean Perspectives in an Organizational Change in a Scientific Direction of an Italian Research Institute : Experience of the Cancer Institute of Bari

enthalten in: International journal of environmental research and public health | 2022

von La Forgia, D. | Paparella, G. | Signorile, R. | +12

6

NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma

enthalten in: Hematological oncology | 2022

von Vegliante, M. | Mazzara, S. | Zaccaria, G. | +34

7

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma

enthalten in: Blood | 2022

von Ferrero, S. | Grimaldi, D. | Genuardi, E. | +23

CommentIn: Blood. 2022 Sep 22;140(12):1332-1333. - PMID 36136360

8

Adenosine pathway inhibitors : novel investigational agents for the treatment of metastatic breast cancer

enthalten in: Expert opinion on investigational drugs | 2022

von Rizzo, A. | Massafra, R. | Fanizzi, A. | +10

9

Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer

enthalten in: Expert opinion on investigational drugs | 2022

von Rizzo, A. | Massafra, R. | Fanizzi, A. | +10

10

NR1H3(LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma

enthalten in: Hematological Oncology | 2022

von Vegliante, M. | Mazzara, S. | Zaccaria, G. | +34